View more in
Health

Third member of FDA advisory panel resigns over Alzheimer's drug approval

Posted by 
NBC News
NBC News
 3 days ago

Cover picture for the articleA third member of a panel of outside advisers to the U.S. Food and Drug Administration has resigned in protest over the agency's decision to approve Biogen Inc's Alzheimer's disease treatment despite the committee's recommendation against doing so. Aaron Kesselheim, a Professor of Medicine at Harvard Medical School who had...

www.nbcnews.com
View All 2 Commentsarrow_down